Tokyo, Japan

Naoki Miyoshi


 

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2009-2024

where 'Filed Patents' based on already Granted Patents

5 patents (USPTO):

Title: Naoki Miyoshi: Innovator in Pharmaceutical Chemistry

Introduction

Naoki Miyoshi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for treating various diseases. With a total of five patents to his name, Miyoshi's work has the potential to impact the medical community significantly.

Latest Patents

One of Miyoshi's latest patents involves azole derivatives as apelin receptor agonists. This invention relates to a novel azole derivative that serves as an apelin receptor agonist, providing a method for treating cardiovascular diseases, diabetes, renal diseases, hypertension, and arteriosclerosis. The patent outlines a compound represented by a specific formula, which includes various groups that enhance its pharmacological properties.

Career Highlights

Throughout his career, Naoki Miyoshi has worked with esteemed organizations such as the Sanford Burnham Prebys Medical Discovery Institute and Sony Corporation. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Miyoshi has collaborated with notable coworkers, including Takuya Ikeda and Yoshiyuki Kobayashi. These partnerships have fostered an environment of innovation and creativity, leading to advancements in pharmaceutical research.

Conclusion

Naoki Miyoshi's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a key figure in the field. His work continues to pave the way for new treatments and advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…